The impact of antibiotic use on children's recovery from community- acquired pneumonia | [Pakistan Journal of Pharmaceutical Sciences • 2025]

Author(s):

1. Aifang Yang: Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University, China ·

2. Yanyan Lu: Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University, China ·

3. Yan Zhou: Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University, China ·

Abstract:

This retrospective study aims to explore the impact of rational antibiotic use on community-acquired pneumonia (CAP) children's recuperation. A retrospective analysis was performed on clinical data of 1078 children with CAP treated in Nanjing First Hospital, Nanjing Medical University from May 2021 to October 2024. Children were divided into good and poor recovery outcome groups. Related datas were compared between groups. Parameters with statistical significance (P < 0.05) underwent logistic regression. A predictive model for poor outcomes was developed and evaluated using ROC curve, AUC and DCA for combined predictive efficacy. The poor-recovery group had a higher proportion of children with parental smoking history, severe pneumonia, mixed infections, longer antibiotic use, CRP and PCT levels (all P < 0.05), but a lower rate of combined drug treatment (P < 0.05). Multivariate Logistic regression identified severe pneumonia (OR=1.554, 95% CI: 1.136-2.124), longer antibiotic courses (OR=1.254, 95% CI: 1.152-1.364) and elevated CRP/PCT levels as independent risk factors. The predictive model showed an AUC of 0.847 (95% CI: 0.802-0.893), with a 23.8% recovery difference between groups. Combined antibiotic use, antibiotic duration and inflammation level were independent factors significantly affecting CAP children's recovery, highlighting the critical role of rational medication in CAP outcomes.

Page(s): 1213-1220

DOI: 10.36721/PJPS.2025.38.4.REG.14144.1

Published: Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 4, Year: 2025

Keywords:

Efficacy , Treatment , Antibiotics , Community acquired pneumonia

References:

[1] Bassetti M,Giacobbe DR,Magnasco L,Fantin A,Vena A,Castaldo N A .2024 .Antibiotic strategies for severe community-acquired pneumonia. Semin. Respir. Crit. Care. Med, 45(2) : 187-199.

[2] Calabretta D,Martìn-L I and Torres A .2024 .New guidelines for severe community-acquired pneumonia. Semin. Respir. Crit. Care. Med, 45(2) : 274-286.

[3] Carella F,Aliberti S,Stainer A,Voza A,Blasi F A .2024 .Long-term outcomes in severe community-acquired pneumonia. Semin. Respir. Crit. Care. Med, 45(2) : 266-273.

[4] Cotter JM,Hall M,Neuman MI,Blaschke AJ,Brogan TV,Cogen JD,Gerber JS,Hersh AL,Lipsett SC,Shapiro DJ,Ambroggio L DJ .2024 .Antibiotic route and outcomes for children hospitalized with pneumonia. J. Hosp. Med, 19(8) : 693-701.

[5] Cotter JM,Zaniletti I,Williams DJ,Ramgopal S,Fritz CQ,Taft M,Hall M,Temte E,Stassun J,Trivedi K,Kapes J,Lavey J,Kempe A,Ambroggio L A .2024 .Association between initial antibiotic route and outcomes for children hospitalized with pneumonia. J. Hosp. Med, 20(3) : 238-247.

[6] Daley MF,Reifler LM,Sterrett AT,Poole NM,Winn DB,Steiner JF .2024 .Improving antibiotic prescribing for children with communityacquired pneumonia in outpatient settings. J. Pediatr., 274 : 114155.

[7] Del Rosal T,Bote-Gascón P,Falces-Romero I,Sainz T,Baquero-Artigao F,Rodríguez-Molino P,MéndezEchevarría A,Bravo-Queipo-de-Llano B,Alonso LA,Calvo C .2024 .Multiplex PCR and antibiotic use in children with community-acquired pneumonia. Children, 11(2) : 245.

[8] Fésüs A,Baluku P,Sipos É,Somodi S,Berczi-Kun E,Lekli I,Bácskay I,Benkő R,Vaskó A .2024 .The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): A before-after study. Front, 15 : 1406960.

[9] Gao Y,Liu M,Yang K,Zhao Y,Tian J,Pernica JM,Guyatt G JM .2023 .Shorter versus longer-term antibiotic treatments for community-acquired pneumonia in children: A meta-analysis. Pediatrics, 151(6) : e2022060097.

[10] Kuitunen I,Renko M .2024 .How long antibiotic treatment is needed for community-acquired pneumonia in children?. Pediatr. Infect. Dis. J., 43(1) : e14-e15.

[11] Mao S and Wu L .2024 .Coinfection of viruses in children with community-acquired pneumonia. BMC Pediatr, 24(1) : 457.

[12] Meyer Sauteur PM .2024 .Childhood communityacquired pneumonia. Eur. J. Pediatr., 183(3) : 1129-1136.

[13] Nguyen PTK,Robinson PD,Fitzgerald DA,Marais BJ .2023 .The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia. Front Pediatr, 11 : 1095166.

[14] Puzz L,Plauche EA,Cretella DA,Harrison VA,Wingler MJB .2023 .Evaluation of a pediatric community-acquired pneumonia antimicrobial stewardship intervention at an academic medical center. Antibiotics, 12(4) : 780.

[15] Rosenberg K .2023 .Consider short course of antibiotics for children with nonsevere community-acquired pneumonia. Am. J. Nurs., 123(3) : 62.

[16] RRyu J,Kim NH,Ohn JH,Lim Y,Lee J,Kim HW,Kim SW,Park HS,Kim ES,Yoon S,Heo E,Kim ES .2024 .Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia. Sci. Rep, 14(1) : 22669.

[17] Singla S,Sih K,Goldman RD K .2023 .Antibiotic treatment duration for community-acquired pneumonia in children. , 69(6) : 400-402.

[18] Vaughn VM,Dickson RP,Horowitz JK,Flanders SA .2024 .Community-acquired pneumonia: A review. JAMA., 332(15) : 1282-1295.

[19] Giezeman Westerdahl E,M Westerdahl E .2024 .Many barriers to overcome before the 'no antibiotic' approach to mild community-acquired pneumonia in young children can become a routine practice. Evid. Based. Nurs, : .

[20] Yarahuan JKW,Kisvarday S,Kim E,Yan AP,Nakamura MM,Jones SB,Hron JD .2024 .An algorithm to assess guideline concordance of antibiotic choice in community-acquired pneumonia. Hosp, 14(2) : 137-145.

[21] Zusman O,Avni T,Leibovici L,Adler A,Friberg L,Stergiopoulou T,Carmeli Y,Paul M Y .2013 .Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. , 57(10) : 5104-5111.

Citations

Downloads

Views